ビジュアル版 がんの教科書

発行日：2006年5月
出版社：三省堂
157ページ

最新のがんの診断から治療までをわかりやすく解説！
500点の図解と写真で正確にがんが理解できる本。

切らずに治すがん治療―最新の「放射線治療」がわかる本

発行日：2007年6月
出版社：法研
231ページ

命と向き合う–老いと日本人とがんの壁

発行日：2006年12月
出版社：小学館
160ページ

中川恵一 /
養老孟司（解剖学者 / 医学博士 / 北里大教授 / 東京大学名誉教授）/
和田秀樹（国際医療福祉大学臨床心理学専攻教授 / 精神科医）

自分を生ききる―日本のがん医療と死生観

発行日：2005年7月
出版社：小学館
159ページ

中川恵一 /
養老孟司（解剖学者 / 医学博士 / 北里大教授 / 東京大学名誉教授）

英文原著

2022

Enomoto A, Fukasawa T, Terunuma H, Nakagawa K, Yoshizaki A, Sato S, Miyagawa K. Decrease in MAP3Ks expression enhances the cell death caused by hyperthermia.Int J Hyperthermia.39(1):200-208,2022

Ozaki S, Kaji S, Nawa K, Imae T, Aoki A, Nakamoto T, Ohta T, Nozawa Y,Yamashita H, Haga A, Nakagawa K. Training of deep cross-modality conversion models with a small dataset, and their application in megavoltage CT to kilovoltage CT conversion. Med Phys. 2022

英文原著

2021

Katano A, Yamashita H, Nakagawa K. Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer. Cureus. 13(2):e13199,2021

Katano A, Takenaka R, Yamashita H, Ando M, Yoshida M, Saito Y, Asakage T, Abe O, Nakagawa K. A retrospective analysis of radiotherapy in the treatment of external auditory canal carcinoma. Mol Clin Oncol.14(3):45,2021

Ogita M, Kawamori J, Yamashita H, Nakagawa K. Palliative radiotherapy for gross hematuria in patients with advanced cancer. Sci Rep.11(1):9533,2021

Indo HP, Ito H, Nakagawa K, Chaiswing L, Majima HJ. Translocation of HSP47 and generation of mitochondrial reactive oxygen species in human neuroblastoma SK-N-SH cells following electron and X-ray irradiation. Arch Biochem Biophys.703:108853,2021

Kitaguchi M, Yamashita H, Takenaka R, Okuma K, Nawa K, Nakagawa K. Helical Skin Radiation Therapy Including Total Skin Radiation Therapy Using Tomotherapy for Primary Cutaneous Lymphoma With Bone Marrow Suppression as a Related Adverse Event. Pract Radiat Oncol.11(3):e308-e321,2021

Katano A, Ishida A, Yamashita H, Nakagawa K. Radiotherapy for symptom palliation of splenomegaly in patients with haematological malignancies. Mol Clin Oncol.14(6):114,2021

Ogita M, Yamashita H, Nozawa Y, Ozaki S, Sawayanagi S, Ohta T,Nakagawa K. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison. Radiat Oncol.16(1):107,2021

Jinnouchi H, Yamashita H, Kiritoshi T, Miki Y, Katano A, Nakagawa K, Abe O.Prognostic value of pre-treatment maximum standardized uptake value and CRP in radiotherapy of esophageal cancer. Mol Clin Oncol.15(1):146,2021

Katano A, Yamashita H, Nakagawa K. Radical radiotherapy for localized cutaneous angiosarcoma of the scalp. Mol Clin Oncol.15(3):195,2021

Minamitani M, Mukai T, Ogita M, Yamashita H, Katano A, Nakagawa K. Relationship between Consulting for Second Medical Opinions, Radiotherapy, and Satisfaction with Therapy, Analyzed by Structural Equation Modeling: A Web-Based Survey. Asian Pac J Cancer Prev.22(9):2889-2896,2021

Minamitani M, Mukai T, Yamashita H, Katano A, Nakagawa K. Effects on annual income changes after radical radiotherapy versus after prostatectomy in patients with localized prostate cancer with a specific employment status: A web-based pilot study. PLoS One.16(9):e0258116,2021

英文原著

2020

Ito T, Hanafusa N, Iwase S, Noiri E, Nangaku M, Nakagawa K, Miyagawa K. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy. Ther Apher Dial.24(1), 90-95, 2020.

Kida S, Kaji S, Nawa K, Imae T, Nakamoto T, Ozaki S, Ohta T, Nozawa Y, Nakagawa K. Visual enhancement of Cone-beam CT by use of CycleGAN. Med Phys.47(3), 998-1010, 2020.

Ogita M, Yamashita H, Sawayanagi S, Takahashi W, Nakagawa K. Efficacy of hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer. Jpn J Clin Oncol.9;50(3),303-309, 2020.

Aoki S, Yamashita H, Takahashi W, Nawa K, Ota T, Imae T, Ozaki S, Nozawa Y, Nakajima J, Sato M, Anraku M, Nitadori J, Karasaki T, Abe O, Nakagawa K. Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients. Oncol Lett.19(4), 2695-2704, 2020.

Ogita M, Shiraishi K, Karasawa K, Tokumasu K, Nakajima N, Chang T, Kawamori J, Yamashita H, Nakagawa K: Clinical outcome of adjuvant radiotherapy for squamous cell carcinoma of the breast; a multicenter retrospective cohort study. The Breast 52, 88-94, 2020.

Imae T, Haga A, Watanabe Y, Takenaka S, Shiraki T, Nawa K, Ogita M, Takahashi, W, Yamashita H, Nakagawa K, Abe O. Retrospective dose reconstruction of prostate stereotactic body radiotherapy using cone-beam CT and a log file during VMAT delivery with flattening-filter-free mode. Radiol Phys Technol.13(3):238-248,2020

Imae T, Takenaka S, Watanabe Y, Aoki A, Matsuda K, Sasaki K, Saegusa S, Nawa K, Nakagawa K, Abe O. Surface and build-up dose comparison between Elekta 6 MV flattening filter and flattening-filter-free beams using an advanced Markus ionization chamber and a solid water-equivalent phantom. J Appl Clin Med Phys.21(12):334-339,2020

英文原著

2019

Haga A, Takahashi W, Aoki S, Nawa K, Yamashita H, Abe O, Nakagawa K. Standardization of imaging features for radiomics analysis. J Med Invest. 66(1.2), 35-37, 2019.

Katano A, Yamashita H, Nakagawa K. Successful definitive concurrent chemoradiotherapy in a patient with esophageal cancer and Child-Pugh B cirrhosis of the liver. J Cancer Res Ther. 15(1), 255-257, 2019.

Bhusal Chhatkuli R, Demachi K, Uesaka M, Nakagawa K, Haga A. Development of a markerless tumor-tracking algorithm using prior four-dimensional cone-beam computed tomography. J Radiat Res. 1;60(1), 109-115, 2019.

Satoru Taguchi, Kenshiro Shiraishi, Tetsuya Fujimura, Akihiro Naito, Taketo Kawai, Keiichi Nakagawa, Osamu Abe, Haruki Kume, Hiroshi Fukuhara. Robot-assisted radical prostatectomy versus volumetric modulated arc therapy: Comparison of front-line therapies for localized prostate cancer. Radiotherapy and Oncology 140, 62-67, 2019.

Gonoi W, Okuma H, Hayashi TY, Akahane M, Nakai Y, Tateishi R, Mizuno S, Suzuki, Y, Mitsuda M, Matsuda K, Nakagawa K, Isayama H, Miyagawa K, Koike K, Abe O. Development of pancreatic cancer during observation for hepatocellular carcinoma: A retrospective cohort study. Saudi J Gastroenterol.25(6), 390-396, 2019.

Mizutani T, Magome T, Igaki H, Haga A, Nawa K, Sekiya N, Nakagawa K. Optimization of treatment strategy by using a machine learning model to predict survival time of patients with malignant glioma after radiotherapy.J Radiat Res.22;60(6), 818-824, 2019.

Takenaka R, Haga A, Nawa K, Hideomi Y, Nakagawa K. Improvement of the robustness to set up error by a virtual bolus in total scalp irradiation with Helical TomoTherapy. Radiol Phys Technol.12(4), 433-437, 2019.

Takahashi S, Takahashi W, Tanaka S, Haga A, Nakamoto T, Suzuki Y, Mukasa A, Takayanagi S, Kitagawa Y, Hana T, Nejo T, Nomura M, Nakagawa K, Saito N. Radiomics Analysis for Glioma Malignancy Evaluation Using Diffusion Kurtosis and Tensor Imaging. Int J Radiat Oncol Biol Phys.15;105(4), 784-791, 2019.

Enomoto A, Fukasawa T, Tsumoto H, Karube M, Nakagawa K, Yoshizaki A, Sato S, Miura Y, Miyagawa K. Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation. Sci Rep.5;9(1), 16010, 2019.

Takahashi W, Nawa K, Haga A, Yamashita H, Imae T, Ogita M, Okuma K, Abe O, Nakagawa K. Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy. Clin Transl Radiat Oncol.14;20, 9-12, 2019.

Nakamoto T, Takahashi W, Haga A, Takahashi S, Kiryu S, Nawa K, Ohta T, Ozaki S, Nozawa Y, Tanaka S, Mukasa A, Nakagawa K. Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis. Sci Rep.19;9(1), 19411, 2019.

英文原著

2018

Haga A, Takahashi W, Aoki S, Nawa K, Yamashita H, Abe O, Nakagawa K. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis. Radiol Phys Technol. 11(1), 27-35, 2018.

Aoki S, Yamashita H, Haga A, Nawa K, Imae T, Takahashi W, Abe O, Nakagawa K. Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique. Oncol Lett. 15(3), 3928-3936, 2018.

Sawayanagi S, Yamashita H, Ogita M, Kiritoshi T, Nakamoto T, Abe O, Nakagawa K. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer. Radiat Oncol. 17;13(1), 70, 2018.

Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, Saito Y, Abe O, Nakagawa K. Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: A retrospective study. Medicine (Baltimore). 97(18), e0502, 2018.

Tsuchiya T, Shiraishi K, Nakagawa K, Kim JR, Kanegasaki S. Identification of the active portion of the CCL3 derivative reported to induce antitumor abscopal effect. Clin Transl Radiat Oncol. 23, 10:7-12, 2018.

Kida S, Nakamoto T, Nakano M, Nawa K, Haga A, Kotoku J, Yamashita H, Nakagawa K. Cone Beam Computed Tomography Image Quality Improvement Using a Deep Convolutional Neural Network. Cureus. 29;10(4), e2548, 2018.

Aoki S, Yamashita H, Haga A, Ota T, Takahashi W, Ozaki S, Nawa K, Imae T, Abe O, Nakagawa K. Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study. Oncol Lett. 16(4), 4498-4506, 2018.

英文原著

2017

Takenaka R, Haga A, Yamashita H, Nakagawa K. Adequate target volume in total-body irradiation by intensity-modulated radiation therapy using helical tomotherapy: a simulation study. J Radiat Res. 1;58(2), 210-216, 2017.

Sekiya N, Kuroda Y, Nakajima K, Iwamitsu Y, Kanai Y, Miyashita M, Kotani M, Kitazawa Y, Yamashita H, Nakagawa K. Views on life and death of physicians, nurses, cancer patients and general population in Japan. PLoS One. 3;12(5), e0176648, 2017.

Yamashita H, Seto Y, Takenaka R, Okuma K, Kiritooshi T, Mori K, Yamada K, Fukuda T, Kaminishi M, Abe O, Nakagawa K. Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study. PLoS One. 9;12(5), e0177133, 2017.

Yamashita H, Abe O, Nakagawa K. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study. Radiother Oncol. 123(3), 488, 2017.

Keiichi Nakagawa, Kanabu Nawa, Masatoshi Hashimoto, Shuri Aoki, Yoshihiro Kaneko,Hideomi Yamashita, Akihiro Haga A Half-Arc Multiple Deep-Inspiration Breath-Hold Volumetric Modulated Arc Therapy for a Lung Tumor with 10 MV Flattening-Filter-Free Beams and an Image Sensor Measuring a Distance Map to Thorax Surface: An Initial Clinical Experience.　International Journal of Medical Physics, Clinical Engineering and Radiation Oncology.6, 31-35, 2017.

Sakata D, Haga A, Kida S, Imae T, Takenaka S, Nakagawa K. Effective atomic number estimation using kV-MV dual-energy source in LINAC. Phys Med. 39, 9-15, 2017.

Sakuramachi M, Igaki H, Ikemura M, Yamashita H, Okuma K, Sekiya N, Hayakawa Y, Sakumi A, Takahashi W, Hasegawa H, Fukayama M, Nakagawa K. Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study. Oncol Lett. 14(2), 2033-2040, 2017.

Nakano M, Haga A, Kotoku J, Magome T, Masutani Y, Hanaoka S, Kida S, Nakagawa K. Cone-beam CT reconstruction for non-periodic organ motion using time-ordered chain graph model. Radiat Oncol. 4;12(1), 145, 2017.

Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions witt conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol. 21;12(1), 156, 2017.

Karube M, Yamamoto N, Tsuji H, Kanematsu N, Nakajima M, Yamashita H, Nakagawa K, Kamada T. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy. Radiother Oncol. 125(1), 31-35, 2017.

Katano A, Yamashita H, Nakagawa K. Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases. Mol Clin Oncol. 7(4), 681-686, 2017.

Nawa K, Haga A, Nomoto A, Sarmiento RA, Shiraishi K, Yamashita H, Nakagawa K. Evaluation of a commercial automatic treatment planning system for prostate cancers. Med Dosim. 42(3), 203-209, 2017.

Katano A, Yamashita H, Nakagawa K. Stereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report. Mol Clin Oncol. 7(6), 1061-1063, 2017.

Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, Saito Y, Abe O, Nakagawa K. The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. Sci Rep. 19;7(1), 17805, 2017.

Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol. 21;12(1), 156, 2017.